Hematology - European Medical Journal

Continue

Hematology

Filter
5 Mins
25 Jun 2025

From Bench to Bedside and Back: An Interview with Joshua Richter

Joshua Richter – Associate Professor, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. What initially…
4 Mins
20 May 2025

Update on Tabelecleucel▼ Trial

Latest data from the global ALLELE study confirms the benefits of tabelecleucel cell therapy for transplant recipients who go on to develop a rare but often fatal blood cancer.
24 Apr 2025

Case Report of a Patient Presenting with Acute Flank Pain

A female in her 40s, with a history of heavy smoking presented to the emergency department with a 6-hour history of paraesthesia and…
6 Mins
1 Apr 2025

Entering a New Era in Protection in Haemophilia A

Haemophilia A (HA), defined by factor VIII (FVIII) levels ≤40 IU/dL, is a chronic condition with consequences beyond bleeding…
31 Oct 2024

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
9 Mins
11 Sep 2024

The ITP Treatment Landscape

The limitations of currently available therapies for immune thrombocytopenia (ITP) mean that long-term responses are difficult to maintain…
9 Mins
14 Aug 2024

Recent Advancements in wAIHA

AIHA is an acquired, heterogeneous group of rare diseases with a prevalence of 17 per 100,000.1 This group includes wAIHA…
7 Mins
25 Jul 2024

Normalisation of Haemostasis in Haemophilia A

Haemophilia A is an inherited deficiency in coagulation FVIII. Based on their residual FVIII activity levels, PwHA are considered to have…
We’ve noticed you’re accessing
from North/South America.